Living Conditions and Breast Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

684 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-05-31

Study Completion Date

2013-11-18

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objective of this study is to estimate of the link (odds ratio) between the precariousness defined by the score SPICE (2 groups: precarious and insecure) and stage at diagnosis (2 groups: CAS: stages 1 or 2 the "good prognosis "versus the witnesses: stage 3 or 4 bad prognosis).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Predictive Clinical and Biological Parameters in Breast Cancer

NCT01521676

Breast Cancer

RECRUITING NA

What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol

NCT04359420

Breast Cancer

COMPLETED NA

Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer Survivors

NCT01627366

Breast Cancer

COMPLETED NA

Susceptibility to Breast Cancer

NCT00004565

Breast Cancer Healthy

COMPLETED

A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients

NCT00355316

Breast Neoplasms

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Our secondary objectives include:

* To study the link between cancer stage at diagnosis and diverse parameters describing living conditions
* To construct a new score for social fragility based on new data collected in this study, and to compare this score with the EPICES score
* To study patient quality of life at study baseline

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Neoplasms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cases - Stage III-IV breast cancer

The women in this group have been diagnosed with stage III-IV incident cancer.

No interventions assigned to this group

Controls: Stage I-II breast cancer

The women in this group have been diagnosed with stage I-II incident cancer.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient has been correctly informed about the study, and agrees to participate
* The patient must be insured or beneficiary of a health insurance plan
* Incident breast cancer cases (diagnosis based on pathology) excluding sarcoma, classifiable as stage III-IV, surgical cases

* Patient has been correctly informed about the study, and agrees to participate
* The patient must be insured or beneficiary of a health insurance plan
* Incident breast cancer cases (diagnosis based on pathology) excluding sarcoma, classifiable as stage I-II, surgical cases

Exclusion Criteria

* The patient is in an exclusion period determined by a previous study
* The patient is under judicial protection, under tutorship or curatorship
* The patient is pregnant, parturient, or breastfeeding
* The patient is opposed to study participation
* Women not able to answer a questionnaire due to language barriers or due to vascular or degenerative cerebral dysfunction
* It is impossible to correctly inform the patient

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No